
    
      GW has shown in phase II and III studies that Sativex has analgesic properties that are
      effective in relieving neuropathic pain. These studies suggested that Sativex is well
      tolerated and may also improve sleep and quality of life. GW is conducting this study to
      further demonstrate these effects.
    
  